drugset / Trial / NCT03187301
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
RandomizedCrossoverQuadruple-blindTreatment
Summary
A cardiac safety study of an investigational drug to see how it affects the heart in people with Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Timeline
- Start
- 2017-08-03
- Primary completion
- 2017-12-21
- Completion
- 2017-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apomorphine | Unknown | — | — |
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |